Edesa Biotech (NASDAQ:EDSA – Get Free Report) and Sana Biotechnology (NASDAQ:SANA – Get Free Report) are both small-cap medical companies, but which is the better stock? Get Edesa Biotech alerts:Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Edesa Biotech N/A N/A -$6.17 million ($1.32) -1.86 Sana Biotechnology N/A N/A -$266.76 million ($1.06) -3.34Analyst RatingsSana Biotechnology is trading at a lower price-to-earnings ratio than Edesa Biotech, indicating that it is currently the more affordable of the two stocks. This is a breakdown of current recommendations for Edesa Biotech and Sana Biotechnology, as reported by MarketBeat. Given Sana Biotechnology’s higher probable upside, analysts plainly believe Sana Biotechnology is more favorable than Edesa Biotech. Net Margins Return on Equity Return on Assets Edesa Biotech N/A -162.95% -60.33% Sana Biotechnology N/A -91.96% -43.07%Institutional & Insider Ownership5.5% of Edesa Biotech shares are held by institutional investors.